Johnson & Johnson

JNJ · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.979%

12M weight contribution

+0.156 pp

3M weight contribution

+0.095 pp

12M price return

+37.6%

Share of matched S&P 500 members

Monthly observations through Nov 2025

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Nov 2025	$498.5bn	0.979%	+0.156 pp	+37.6%	Yes
Oct 2025	$455.0bn	0.891%	-0.013 pp	+22.0%	Yes
Sep 2025	$446.6bn	0.894%	-0.014 pp	+18.1%	Yes
Aug 2025	$426.7bn	0.885%	-0.080 pp	+10.3%	Yes
Jul 2025	$396.8bn	0.837%	+0.156 pp	+7.8%	No
Jun 2025	$367.5bn	0.792%	+0.133 pp	+7.9%	No
May 2025	$373.4bn	0.846%	+0.171 pp	+9.3%	No
Apr 2025	$376.1bn	0.903%	-0.106 pp	+11.6%	Yes
Mar 2025	$399.3bn	0.948%	-0.109 pp	+8.2%	Yes
Feb 2025	$397.3bn	0.889%	-0.225 pp	+5.5%	Yes
Jan 2025	$366.3bn	0.815%	-0.323 pp	-1.2%	No
Dec 2024	$348.2bn	0.790%	-0.336 pp	-4.8%	No
Nov 2024	$373.2bn	0.824%	-0.337 pp	+3.4%	No
Oct 2024	$384.9bn	0.905%	-0.309 pp	+11.2%	Yes
Sep 2024	$390.1bn	0.908%	-0.444 pp	+7.3%	Yes
Aug 2024	$399.3bn	0.965%	-0.374 pp	+5.8%	Yes
Jul 2024	$380.0bn	0.681%	-0.268 pp	-2.8%	No
Jun 2024	$351.8bn	0.659%	-0.335 pp	-8.9%	No
May 2024	$353.0bn	0.675%	-0.321 pp	-2.4%	No
Apr 2024	$348.3bn	1.009%	-0.428 pp	-9.0%	No
Mar 2024	$381.0bn	1.057%	-0.320 pp	+5.2%	No
Feb 2024	$388.7bn	1.114%	-0.289 pp	+8.5%	No
Jan 2024	$382.5bn	1.137%	-0.325 pp	+0.2%	No
Dec 2023	$377.3bn	1.125%	-0.541 pp	-8.6%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.